{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:04:56Z","timestamp":1789668296465,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171819"],"award-info":[{"award-number":["82171819"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81930122"],"award-info":[{"award-number":["81930122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U20A20361"],"award-info":[{"award-number":["U20A20361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["2022045"],"award-info":[{"award-number":["2022045"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Project of China","award":["2021YFC2102100"],"award-info":[{"award-number":["2021YFC2102100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Engineered strains of <jats:italic>Escherichia coli<\/jats:italic> have been used to produce bioconjugate vaccines using Protein Glycan Coupling Technology (PGCT). Nanovaccines have also entered the vaccine development arena with advances in nanotechnology and have been significantly developed, but chassis cells for conjugate nanovaccines have not been reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>To facilitate nanovaccine preparation, a generic recombinant protein (SpyCather4573) was used as the acceptor protein for O-linked glycosyltransferase PglL, and a glycol-engineered <jats:italic>Escherichia coli<\/jats:italic> strain with these two key components (SC4573 and PglL) integrated in its genome was developed in this study. The targeted glycoproteins with antigenic polysaccharides produced by our bacterial chassis can be spontaneously bound to proteinous nanocarriers with surface exposed SpyTag in vitro to form conjugate nanovaccines. To improve the yields of the targeted glycoprotein, a series of gene cluster deletion experiments was carried out, and the results showed that the deletion of the <jats:italic>yfdGHI<\/jats:italic> gene cluster increased the expression of glycoproteins. Using the updated system, to the best of our knowledge, we report for the first time the successful preparation of an effective <jats:italic>Klebsiella pneumoniae<\/jats:italic> O1 conjugate nanovaccine (KPO1-VLP), with antibody titers between 4 and 5 (Log10) after triple immunization and up to 100% protection against virulent strain challenge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results define a convenient and reliable framework for bacterial glycoprotein vaccine preparation that is flexible and versatile, and the genomic stability of the engineered chassis cells promises a wide range of applications for biosynthetic glycobiology research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12934-023-02099-x","type":"journal-article","created":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T12:02:28Z","timestamp":1683374548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Preparation of a Klebsiella pneumoniae conjugate nanovaccine using glycol-engineered Escherichia coli"],"prefix":"10.1186","volume":"22","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanGe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,6]]},"reference":[{"issue":"6","key":"2099_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/14760584.2020.1775077","volume":"19","author":"JM Dow","year":"2020","unstructured":"Dow JM, et al. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production. Expert Rev Vaccines. 2020;19(6):507\u201327.","journal-title":"Expert Rev Vaccines"},{"issue":"18","key":"2099_CR2","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1073\/pnas.0509207103","volume":"103","author":"M Wacker","year":"2006","unstructured":"Wacker M, et al. Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc Natl Acad Sci U S A. 2006;103(18):7088\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2099_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2217\/fmb.09.10","volume":"4","author":"RH Langdon","year":"2009","unstructured":"Langdon RH, Cuccui J, Wren BW. N-linked glycosylation in bacteria: an unexpected application. Future Microbiol. 2009;4(4):401\u201312.","journal-title":"Future Microbiol"},{"issue":"12","key":"2099_CR4","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.4161\/hv.26109","volume":"9","author":"ME Pichichero","year":"2013","unstructured":"Pichichero ME. Protein carriers of conjugate vaccines: characteristics, development, and clinical trials. Hum Vaccin Immunother. 2013;9(12):2505\u201323.","journal-title":"Hum Vaccin Immunother"},{"issue":"5599","key":"2099_CR5","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1126\/science.298.5599.1790","volume":"298","author":"M Wacker","year":"2002","unstructured":"Wacker M, et al. N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science. 2002;298(5599):1790\u20133.","journal-title":"Science"},{"key":"2099_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/978-3-030-58971-4_6","volume":"96","author":"H Bohl","year":"2021","unstructured":"Bohl H, Bai L, Li H. Recent progress in structural studies on the GT-C superfamily of protein glycosyltransferases. Subcell Biochem. 2021;96:259\u201371.","journal-title":"Subcell Biochem"},{"issue":"22","key":"2099_CR7","doi-asserted-by":"publisher","first-page":"8088","DOI":"10.1128\/JB.01318-07","volume":"189","author":"A Faridmoayer","year":"2007","unstructured":"Faridmoayer A, et al. Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation. J Bacteriol. 2007;189(22):8088\u201398.","journal-title":"J Bacteriol"},{"issue":"2","key":"2099_CR8","doi-asserted-by":"publisher","first-page":"e00443","DOI":"10.1128\/mBio.00443-16","volume":"7","author":"C Pan","year":"2016","unstructured":"Pan C, et al. Biosynthesis of conjugate vaccines using an O-linked glycosylation system. mBio. 2016;7(2):e00443-16.","journal-title":"mBio"},{"issue":"5","key":"2099_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/mmi.12986","volume":"96","author":"CM Harding","year":"2015","unstructured":"Harding CM, et al. Acinetobacter strains carry two functional oligosaccharyltransferases, one devoted exclusively to type IV pilin, and the other one dedicated to O-glycosylation of multiple proteins. Mol Microbiol. 2015;96(5):1023\u201341.","journal-title":"Mol Microbiol"},{"issue":"9","key":"2099_CR10","first-page":"1192","volume":"31","author":"CJ Knoot","year":"2021","unstructured":"Knoot CJ, Robinson LS, Harding CM. A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS. Glycobiology. 2021;31(9):1192\u2013203.","journal-title":"Glycobiology"},{"issue":"6280","key":"2099_CR11","doi-asserted-by":"publisher","first-page":"aad6253","DOI":"10.1126\/science.aad6253","volume":"351","author":"Hutchison","year":"2016","unstructured":"Hutchison, et al. Design and synthesis of a minimal bacterial genome. Science. 2016;351(6280):aad6253.","journal-title":"Science."},{"issue":"2","key":"2099_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/jb.126.2.999-1001.1976","volume":"126","author":"J Neuhard","year":"1976","unstructured":"Neuhard J, Thomassen E. Altered deoxyribonucleotide pools in P2 eductants of Escherichia coli K-12 due to deletion of the dcd gene. J Bacteriol. 1976;126(2):999\u20131001.","journal-title":"J Bacteriol"},{"issue":"49","key":"2099_CR13","doi-asserted-by":"publisher","first-page":"35129","DOI":"10.1074\/jbc.274.49.35129","volume":"274","author":"MF Feldman","year":"1999","unstructured":"Feldman MF, et al. The activity of a putative polyisoprenol-linked sugar translocase (Wzx) involved in Escherichia coli O antigen assembly is independent of the chemical structure of the O repeat. J Biol Chem. 1999;274(49):35129\u201338.","journal-title":"J Biol Chem."},{"issue":"8","key":"2099_CR14","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1073\/pnas.0500044102","volume":"102","author":"MF Feldman","year":"2005","unstructured":"Feldman MF, et al. Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci. 2005;102(8):3016\u201321.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"2099_CR15","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/j.1365-2958.2005.04519.x","volume":"55","author":"D Linton","year":"2005","unstructured":"Linton D, et al. Functional analysis of the Campylobacter jejuni N-linked protein glycosylation pathway. Mol Microbiol. 2005;55(6):1695\u2013703.","journal-title":"Mol Microbiol"},{"issue":"18","key":"2099_CR16","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1073\/pnas.0509207103","volume":"103","author":"M Wacker","year":"2006","unstructured":"Wacker M, et al. Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc Natl Acad Sci USA. 2006;103(18):7088.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2099_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.emboj.7601024","volume":"25","author":"C Alaimo","year":"2006","unstructured":"Alaimo C, et al. Two distinct but interchangeable mechanisms for flipping of lipid-linked oligosaccharides. Embo J. 2006;25(5):967\u201376.","journal-title":"Embo J"},{"issue":"6","key":"2099_CR18","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1365-2958.2008.06490.x","volume":"70","author":"J P\u00e9rez","year":"2010","unstructured":"P\u00e9rez J, et al. Functional analysis of the large periplasmic loop of the Escherichia coli K-12 WaaL O-antigen ligase. Mol Microbiol. 2010;70(6):1424\u201340.","journal-title":"Mol Microbiol"},{"issue":"1","key":"2099_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/glycob\/cwt087","volume":"24","author":"MA Musumeci","year":"2014","unstructured":"Musumeci MA, et al. Evaluating the role of conserved amino acids in bacterial O-oligosaccharyltransferases by in vivo, in vitro and limited proteolysis assays. Glycobiology. 2014;24(1):39.","journal-title":"Glycobiology"},{"issue":"1","key":"2099_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00271207","volume":"184","author":"D Noack","year":"1981","unstructured":"Noack D, et al. Maintenance and genetic stability of vector plasmids pBR322 and pBR325 in Escherichia coli K12 strains grown in a chemostat. Mol Gen Genet. 1981;184(1):121\u20134.","journal-title":"Mol Gen Genet"},{"issue":"8","key":"2099_CR21","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/bit.260370808","volume":"37","author":"S Birnbaum","year":"1991","unstructured":"Birnbaum S, Bailey JE. Plasmid presence changes the relative levels of many host cell proteins and ribosome components in recombinant Escherichia coli. Biotechnol Bioeng. 1991;37(8):736\u201345.","journal-title":"Biotechnol Bioeng"},{"issue":"5","key":"2099_CR22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/bit.22292","volume":"102","author":"WE Bentley","year":"2009","unstructured":"Bentley WE, et al. Plasmid-encoded protein: the principal factor in the \u201cmetabolic burden\u201d associated with recombinant bacteria. Biotechnol Bioeng. 2009;102(5):1284\u201397.","journal-title":"Biotechnol Bioeng."},{"issue":"7","key":"2099_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011060","volume":"5","author":"MA Apicella","year":"2010","unstructured":"Apicella MA, et al. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS ONE. 2010;5(7): e11060.","journal-title":"PLoS ONE"},{"issue":"35","key":"2099_CR24","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1016\/j.vaccine.2016.06.067","volume":"34","author":"GP van Dobbelsteen","year":"2016","unstructured":"van Dobbelsteen GP, et al. Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models. Vaccine. 2016;34(35):4152\u201360.","journal-title":"Vaccine"},{"issue":"26","key":"2099_CR25","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1016\/j.vaccine.2018.05.036","volume":"36","author":"JA Herbert","year":"2018","unstructured":"Herbert JA, et al. Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine. Vaccine. 2018;36(26):3809\u201319.","journal-title":"Vaccine"},{"issue":"1","key":"2099_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.bbrc.2017.11.023","volume":"495","author":"B Strutton","year":"2018","unstructured":"Strutton B, et al. Producing a glycosylating Escherichia coli cell factory: the placement of the bacterial oligosaccharyl transferase pglB onto the genome. Biochem Biophys Res Commun. 2018;495(1):686\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"2099_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymben.2019.02.002","volume":"53","author":"LE Yates","year":"2019","unstructured":"Yates LE, et al. Glyco-recoded Escherichia coli: recombineering-based genome editing of native polysaccharide biosynthesis gene clusters. Metab Eng. 2019;53:59\u201368.","journal-title":"Metab Eng"},{"issue":"11","key":"2099_CR28","doi-asserted-by":"publisher","first-page":"10621","DOI":"10.1021\/acsnano.8b05950","volume":"12","author":"S Singha","year":"2018","unstructured":"Singha S, et al. Nanoparticles for immune stimulation against infection, cancer, and autoimmunity. ACS Nano. 2018;12(11):10621\u201335.","journal-title":"ACS Nano"},{"issue":"1","key":"2099_CR29","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1038\/s41467-019-13744-8","volume":"10","author":"M Fusciello","year":"2019","unstructured":"Fusciello M, et al. Artificially cloaked viral nanovaccine for cancer immunotherapy. Nat Commun. 2019;10(1):5747.","journal-title":"Nat Commun"},{"issue":"10","key":"2099_CR30","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"D Bobo","year":"2016","unstructured":"Bobo D, et al. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res. 2016;33(10):2373\u201387.","journal-title":"Pharm Res"},{"issue":"42","key":"2099_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002940","volume":"32","author":"C Pan","year":"2020","unstructured":"Pan C, et al. Biosynthesis of self-assembled proteinaceous nanoparticles for vaccination. Adv Mater. 2020;32(42): e2002940.","journal-title":"Adv Mater"},{"issue":"9","key":"2099_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"2099_CR33","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1128\/AAC.01019-15","volume":"59","author":"JD Pitout","year":"2015","unstructured":"Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59(10):5873\u201384.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2099_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.10.014","volume":"55","author":"AA Agyeman","year":"2020","unstructured":"Agyeman AA, et al. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents. 2020;55(1): 105833.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2099_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S1473-3099(21)00399-6","volume":"22","author":"M Wang","year":"2022","unstructured":"Wang M, et al. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. Lancet Infect Dis. 2022;22(3):401\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"37","key":"2099_CR36","doi-asserted-by":"publisher","first-page":"18655","DOI":"10.1073\/pnas.1907833116","volume":"116","author":"MF Feldman","year":"2019","unstructured":"Feldman MF, et al. A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae. Proc Natl Acad Sci U S A. 2019;116(37):18655\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2099_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203143","volume":"13","author":"N Hegerle","year":"2018","unstructured":"Hegerle N, et al. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. PLoS ONE. 2018;13(9): e0203143.","journal-title":"PLoS ONE"},{"issue":"1","key":"2099_CR38","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/s41467-017-02223-7","volume":"8","author":"ME Pennini","year":"2017","unstructured":"Pennini ME, et al. Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae. Nat Commun. 2017;8(1):1991.","journal-title":"Nat Commun"},{"issue":"7","key":"2099_CR39","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1128\/AEM.04023-14","volume":"81","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, et al. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Appl Environ Microbiol. 2015;81(7):2506\u201314.","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"2099_CR40","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s12274-021-3713-4","volume":"15","author":"X Li","year":"2022","unstructured":"Li X, et al. Orthogonal modular biosynthesis of nanoscale conjugate vaccines for vaccination against infection. Nano Res. 2022;15(2):1645\u201353.","journal-title":"Nano Res"},{"issue":"14","key":"2099_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100549","volume":"8","author":"Z Peng","year":"2021","unstructured":"Peng Z, et al. Production of a promising biosynthetic self-assembled nanoconjugate vaccine against Klebsiella pneumoniae serotype O2 in a general Escherichia coli host. Adv Sci (Weinh). 2021;8(14): e2100549.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"2099_CR42","first-page":"1081","volume":"37","author":"X Shen","year":"2021","unstructured":"Shen X, et al. Advances in the research of enterobacterial common antigen. Sheng Wu Gong Cheng Xue Bao. 2021;37(4):1081\u201391.","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"issue":"2","key":"2099_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.plipres.2009.06.002","volume":"49","author":"X Wang","year":"2010","unstructured":"Wang X, Quinn PJ. Lipopolysaccharide: biosynthetic pathway and structure modification. Prog Lipid Res. 2010;49(2):97\u2013107.","journal-title":"Prog Lipid Res"},{"issue":"21","key":"2099_CR44","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1016\/j.vaccine.2017.04.002","volume":"35","author":"P Li","year":"2017","unstructured":"Li P, et al. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge. Vaccine. 2017;35(21):2862\u20139.","journal-title":"Vaccine"},{"key":"2099_CR45","doi-asserted-by":"publisher","first-page":"26511","DOI":"10.1038\/srep26511","volume":"6","author":"H Nothaft","year":"2016","unstructured":"Nothaft H, et al. Engineering the Campylobacter jejuni N-glycan to create an effective chicken vaccine. Sci Rep. 2016;6:26511.","journal-title":"Sci Rep"},{"issue":"1","key":"2099_CR46","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41467-019-08869-9","volume":"10","author":"CM Harding","year":"2019","unstructured":"Harding CM, et al. A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host. Nat Commun. 2019;10(1):891.","journal-title":"Nat Commun"},{"issue":"7","key":"2099_CR47","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1128\/JB.01905-06","volume":"189","author":"J Lehrer","year":"2007","unstructured":"Lehrer J, et al. Functional characterization and membrane topology of Escherichia coli WecA, a sugar-phosphate transferase initiating the biosynthesis of enterobacterial common antigen and O-antigen lipopolysaccharide. J Bacteriol. 2007;189(7):2618\u201328.","journal-title":"J Bacteriol"},{"issue":"3","key":"2099_CR48","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(87)90503-4","volume":"50","author":"Y Kohara","year":"1987","unstructured":"Kohara Y, Akiyama K, Isono K. The physical map of the whole E. coli chromosome: application of a new strategy for rapid analysis and sorting of a large genomic library. Cell. 1987;50(3):495\u2013508.","journal-title":"Cell"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-023-02099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12934-023-02099-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-023-02099-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T13:01:55Z","timestamp":1683378115000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbialcellfactories.biomedcentral.com\/articles\/10.1186\/s12934-023-02099-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,6]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2099"],"URL":"https:\/\/doi.org\/10.1186\/s12934-023-02099-x","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,6]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mouse immunizations were performed following the ethical regulations for animal testing and research. All experiments were approved by and conducted following the guidelines of the Institutional Animal Care and Use Committee of the Academy of Military Medical Sciences (ethical approval code IACUC-DWZX-2020-042).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I hereby give the Journal of Microbial Cell Factories the right and permission to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}